BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sposito C, Citterio D, Virdis M, Battiston C, Droz Dit Busset M, Flores M, Mazzaferro V. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World J Gastroenterol 2022; 28(34): 4929-4942 [PMID: 36160651 DOI: 10.3748/wjg.v28.i34.4929]
URL: https://www.wjgnet.com/1007-9327/full/v28/i34/4929.htm
Number Citing Articles
1
Chunhui Zhang, Yuqing Tao, Rui Yang, Yueqi Wang, Yanyan Yu, Yang Zhou. Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2024; : 229 doi: 10.2147/JHC.S412933
2
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapyWorld Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
3
Davide Citterio, Jorgelina Coppa, Carlo Sposito, Michele Droz Dit Busset, Matteo Virdis, Isabella Pezzoli, Vincenzo Mazzaferro. The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine TumorsCurrent Treatment Options in Oncology 2023; 24(11): 1651 doi: 10.1007/s11864-023-01124-w
4
Xin Jin, Xiaoting Ma, Dong Zhao, Lin Yang, Nan Ma. Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantationTranslational Oncology 2023; 28: 101603 doi: 10.1016/j.tranon.2022.101603
5
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsJournal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005